226 related articles for article (PubMed ID: 30761533)
1. Influence of the phenotype on mycosis fungoides prognosis, a retrospective cohort study of 160 patients.
Jaque A; Mereniuk A; Walsh S; Shear NH; Sade S; Zagorski B; Alhusayen R
Int J Dermatol; 2019 Aug; 58(8):933-939. PubMed ID: 30761533
[TBL] [Abstract][Full Text] [Related]
2. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
[TBL] [Abstract][Full Text] [Related]
3. A case-control study of clinicopathologic features, prognosis, and therapeutic responses in patients with granulomatous mycosis fungoides.
Li JY; Pulitzer MP; Myskowski PL; Dusza SW; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2013 Sep; 69(3):366-74. PubMed ID: 23685027
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections.
Izban KF; Hsi ED; Alkan S
Mod Pathol; 1998 Oct; 11(10):978-82. PubMed ID: 9796726
[TBL] [Abstract][Full Text] [Related]
5. Hyperpigmented mycosis fungoides: a retrospective and comparative analysis with other subtypes of mycosis fungoides.
Jung JM; Lee MY; Won CH; Chang SE; Lee MW; Lee WJ
Leuk Lymphoma; 2022 Jul; 63(7):1598-1606. PubMed ID: 35201905
[TBL] [Abstract][Full Text] [Related]
6. Transformation in mycosis fungoides: the role of methotrexate.
Abd-el-Baki J; Demierre MF; Li N; Foss FM
J Cutan Med Surg; 2002; 6(2):109-16. PubMed ID: 11992182
[TBL] [Abstract][Full Text] [Related]
7. Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical course.
Quaglino P; Zaccagna A; Verrone A; Dardano F; Bernengo MG
Dermatology; 1999; 199(1):8-14. PubMed ID: 10449950
[TBL] [Abstract][Full Text] [Related]
8. Double-positive CD4/CD8 mycosis fungoides: a rarely reported immunohistochemical profile.
Tournier E; Laurent C; Thomas M; Meyer N; Viraben R; Brousset P; Lamant L
J Cutan Pathol; 2014 Jan; 41(1):58-62. PubMed ID: 24134789
[TBL] [Abstract][Full Text] [Related]
9. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas.
Vergier B; de Muret A; Beylot-Barry M; Vaillant L; Ekouevi D; Chene G; Carlotti A; Franck N; Dechelotte P; Souteyrand P; Courville P; Joly P; Delaunay M; Bagot M; Grange F; Fraitag S; Bosq J; Petrella T; Durlach A; De Mascarel A; Merlio JP; Wechsler J
Blood; 2000 Apr; 95(7):2212-8. PubMed ID: 10733487
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: a case series of 34 patients.
Boulos S; Vaid R; Aladily TN; Ivan DS; Talpur R; Duvic M
J Am Acad Dermatol; 2014 Dec; 71(6):1117-26. PubMed ID: 25264240
[TBL] [Abstract][Full Text] [Related]
11. CD8
Martinez-Escala ME; Kantor RW; Cices A; Zhou XA; Kaplan JB; Pro B; Choi J; Guitart J
J Am Acad Dermatol; 2017 Sep; 77(3):489-496. PubMed ID: 28676328
[TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
13. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
[TBL] [Abstract][Full Text] [Related]
14. CD4/CD8 dual-positive mycosis fungoides: a previously unrecognized variant.
Knapp CF; Mathew R; Messina JL; Lien MH
Am J Dermatopathol; 2012 May; 34(3):e37-9. PubMed ID: 22356917
[TBL] [Abstract][Full Text] [Related]
15. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients.
Nikolaou VA; Papadavid E; Katsambas A; Stratigos AJ; Marinos L; Anagnostou D; Antoniou C
Br J Dermatol; 2009 Oct; 161(4):826-30. PubMed ID: 19558552
[TBL] [Abstract][Full Text] [Related]
18. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features.
Abbott RA; Sahni D; Robson A; Agar N; Whittaker S; Scarisbrick JJ
J Am Acad Dermatol; 2011 Aug; 65(2):313-319. PubMed ID: 21529998
[TBL] [Abstract][Full Text] [Related]
19. Hypopigmented mycosis fungoides: frequent expression of a CD8+ T-cell phenotype.
El-Shabrawi-Caelen L; Cerroni L; Medeiros LJ; McCalmont TH
Am J Surg Pathol; 2002 Apr; 26(4):450-7. PubMed ID: 11914622
[TBL] [Abstract][Full Text] [Related]
20. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]